A detailed history of Wells Fargo & Company transactions in Sop Hi A Genetics Sa stock. As of the latest transaction made, Wells Fargo & Company holds 700 shares of SOPH stock, worth $2,317. This represents 0.0% of its overall portfolio holdings.

Number of Shares
700
Previous 700 -0.0%
Holding current value
$2,317
Previous $3,000 33.33%
% of portfolio
0.0%
Previous 0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023

BUY
$2.3 - $4.58 $1,609 - $3,206
700 New
700 $1,000

Others Institutions Holding SOPH

About SOPHiA GENETICS SA


  • Ticker SOPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 64,153,700
  • Market Cap $212M
  • Description
  • SOPHiA GENETICS SA operates as a healthcare technology company. The company offers SOPHiA DDM platform, a cloud-based software-as-a-service platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities. Its SOPHiA DDM platform and related solutions, products, and services are used by hospital, laboratory...
More about SOPH
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.